CanSino Biologics
(OTC) CASBF
CanSino Biologics Financials at a Glance
Market Cap
$765.84M
Revenue (TTM)
CN¥1.11B
Net Income (TTM)
-CN¥836.08K
EPS (TTM)
-$0.00
P/E Ratio
-2384.62
Dividend
$0.00
Beta (Volatility)
-0.12 (Low)
Dividend
$0.00
Beta (Volatility)
-0.12 (Low)
Price
$3.10
Volume
1,000
Open
$3.10
Price
$3.10
Volume
1,000
Open
$3.10
Previous Close
$3.10
Daily Range
$3.10 - $3.10
52-Week Range
$3.00 - $6.99
Estimated Earnings Date
Apr 28, 2026
Dividend
$0.00
Beta (Volatility)
-0.12 (Low)
Price
$3.10
Volume
1,000
Open
$3.10
Previous Close
$3.10
Daily Range
$3.10 - $3.10
52-Week Range
$3.00 - $6.99
Estimated Earnings Date
Apr 28, 2026
CASBF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout CanSino Biologics
Industry
Biotechnology
Sector
Health CareEmployees
1,134
CEO
Xue Feng Yu, PhD
Website
www.cansinotech.comHeadquarters
Tianjin, CN
CASBF Financials
Key Financial Metrics (TTM)
Gross Margin
99%
Operating Margin
-0%
Net Income Margin
-0%
Return on Equity
-4%
Return on Capital
-0%
Return on Assets
-0%
Earnings Yield
-0.04%
Dividend Yield
0.00%
Payout Ratio
-23.46%
Stock Overview
Market Cap
$765.84M
Shares Outstanding
247.04M
Volume
1.00K
Avg. Volume
65.609
Financials (TTM)
Gross Profit
CN¥681.87M
Operating Income
-CN¥113.13M
EBITDA
CN¥60.98M
Operating Cash Flow
CN¥32.49M
Capital Expenditure
-CN¥185.33M
Free Cash Flow
-CN¥152.84M
Cash & ST Invst.
CN¥2.65B
Total Debt
CN¥1.29B
CanSino Biologics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CN¥188.46M
+37.4%
Gross Profit
CN¥152.55M
+34.5%
Gross Margin
80.94%
N/A
Market Cap
$765.84M
N/A
Market Cap/Employee
$693.06K
N/A
Employees
1,105
N/A
Net Income
-CN¥40.04M
-246.8%
EBITDA
-CN¥41.75M
-249.4%
Quarterly Fundamentals
Net Cash
CN¥916.17M
-17.1%
Accounts Receivable
CN¥817.60M
+22.8%
Inventory
CN¥399.53M
+23.9%
Long Term Debt
CN¥949.01M
-15.7%
Short Term Debt
CN¥208.25M
-75.7%
Return on Assets
-0.01%
N/A
Return on Invested Capital
-0.03%
N/A
Free Cash Flow
-CN¥88.49M
-9.0%
Operating Cash Flow
-CN¥57.71M
-318.1%